FDA Clears QIAGEN's Gram-Negative QIAstat-Dx Bloodstream Panel, Joining Gram-Positive And Fungal Panel To Cover 33 Pathogen Targets And 28 Resistance Marker

Benzinga

2026.09.28 07:10 (GMT+0)

Открыть на Benzinga